Taiwan FDA registration ed47f1df9c74918307e0fabd1420d9f2
"Inverme" Saclo adsorber
TW: “英弗梅”賽克洛吸附器
Taiwan·Risk Class 3·BELLCO S.R.L.;;Infomed S.A.·Registered Aug 27, 2019 – Aug 27, 2024ExpiredRegistration details
- Analysis ID
- ed47f1df9c74918307e0fabd1420d9f2
- Customs Code
- DHA05603271802
Company information
- Manufacturer
- BELLCO S.R.L.;;Infomed S.A.
- Manufacturer Country
- Italy;;Switzerland
- Authorized Representative
- HEMOSCIEN CORPORATION
Product details
- Intended Use
- SecoLoc adsorbers have hydrophobic adsorbents that adsorb cytokines (IL-1, IL-6, IL-10, TNF-α) and bilirubin. It is suitable for plasma filtration adsorption (CPFA, Coupled Plasma Filtration Adsorption) and plasma perfusion (PP) treatment.
- Product Type (Level 1)
- H Gastroenterology and urology
- Product Type (Level 2)
- H.5870 吸附式血液灌注系統
- Import Information
- Contract manufacturing;; input
Dates and status
- Registration Date
- Aug 27, 2019
- Expiry Date
- Aug 27, 2024
About this record
Access comprehensive regulatory information for "Inverme" Saclo adsorber in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number ed47f1df9c74918307e0fabd1420d9f2 and manufactured by BELLCO S.R.L.;;Infomed S.A.. The authorized representative in Taiwan is HEMOSCIEN CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices